10x Genomics (TXG) concentration risks

The company's disclosed concentration profile is limited to a single supply-side exposure: certain components used in the manufacture of its products are sourced from a single supplier. By disclosed size this is a high-share dependency, meaning the component in question is not merely important but central enough to the supply chain that no alternative sourcing has been disclosed. The character is dependency — the risk is specific to the named single-supplier relationship rather than a broad feature of the end-market or the product category, making it an idiosyncratic exposure that a supply disruption, quality issue, or commercial dispute at that supplier could activate. No customer, geographic, or product concentration is disclosed alongside this. The absence of customer or geographic disclosures implies the company either has a sufficiently distributed customer base that no individual relationship crosses a material threshold, or those dimensions were not flagged as material risks in the most recent filing. On balance, the concentration profile is narrow: a single supply dependency at high disclosed size is the dominant risk surface, and it is the variable most worth monitoring — specifically, whether the company has or is building qualified alternative sources for the affected components. The overall profile does not present a web of compounding concentrations, and the single disclosed exposure, while notable in size, is well understood and disclosed.

For the engine’s reasoning on TXG’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.